NEW YORK (GenomeWeb) – Premaitha Health today announced it has signed a collaboration agreement with Centrum Badan DNA to offer its Iona test for non-invasive prenatal testing in Poland.

Centrum Badan will become Premaitha's preferred testing partner in the country. Financial and other details of the agreement were not disclosed.

The next-generation sequencing-based test analyzes cell-free fetal DNA in the mother's blood to detect genetic disorders such as trisomies 13, 18, and 21.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.